• Phillip Lieberman, Richard A Nicklas, John Oppenheimer, Stephen F Kemp, David M Lang, David I Bernstein, Jonathan A Bernstein, A Wesley Burks, Anna M Feldweg, Jordan N Fink, Paul A Greenberger, David B K Golden, John M James, Dennis K Ledford, Albert L Sheffer, Joann Blessing-Moore, Linda Cox, David A Khan, David Lang, Jay M Portnoy, Christopher Randolph, Diane E Schuller, Sheldon L Spector, Stephen Tilles, and Dana Wallace.
• JointCouncil of Allergy, Asthma&Immunology, 50NBrockway St, #3-3, Palatine, IL 60067, USA. phillieberman@hotmail.com
• J. Allergy Clin. Immunol. 2010 Sep 1; 126 (3): 477-80.e1-42.

AbstractThese parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma and Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "The Diagnosis and Management of Anaphylaxis Practice Parameter: 2010 Update." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, or the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

8 keywords...

hide…